title: Lessons from glargine trials: what is the goal fasting glucose with basal insulin?
authors.affiliation: Mount Sinai School of Medicine, New York, NY, USA. zbloom@gmail.com.
authors.forename: Zachary
authors.initials: Z
authors.lastname: Bloomgarden
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Handelsman
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D005215:Fasting / Q000502:physiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine